ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0072

Identification of AKI Subtypes Using Deep Learning-Based Clustering of Serum Creatinine Trajectories and Clinical Features in Critically Ill Patients

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Author

  • Kang, Min Woo, Korea University Guro Hospital, Guro-gu, Seoul, Korea (the Republic of)
Background

This study aimed to identify subtypes of ICU patients with AKI by clustering serum creatinine trajectories and clinical features, then compare outcomes across clusters.

Methods

In this retrospective MIMIC-IV cohort, ICU patients with KDIGO-defined AKI were included; those with end-stage kidney disease or prior KRT were excluded. We gathered creatinine measurements (7 days before to 4 days after AKI onset), demographics, vitals, comorbidities, nephrotoxin and vasopressor use, sepsis status, cardiac surgery history, and labs. Missing values were imputed. Autoencoders combined with Deep Embedded K-Means yielded ten clusters, optimized via the Davies–Bouldin index. We compared 7-, 14-, and 30-day mortality and KRT initiation rates across clusters.

Results

A total of 30,096 ICU patients with AKI were included, and ten clusters were identified. Baseline creatinine differed significantly among clusters (p<0.001), highest in cluster 6 (2.90 ± 2.62 mg/dL) and lowest in cluster 2 (1.43 ± 1.10 mg/dL). Nephrotoxic medication use was highest in cluster 7 (46.8%) and lowest in cluster 8 (15.1%). Sepsis incidence was highest in cluster 5 (85.4%) and lowest in cluster 1 (14.1%). Regarding creatinine trajectories, clusters 5 and 7 exhibited abrupt elevations, while other clusters showed gradual increases. Clinical outcomes varied significantly across clusters (all p<0.001). The 7-day mortality rate was highest in cluster 3 (2.44%), followed by cluster 6 (0.53%), while the 7-day KRT initiation rate was highest in cluster 7 (25.00%), followed by cluster 8 (3.45%).

Conclusion

Deep learning–based clustering delineated distinct AKI subtypes with divergent trajectories and outcomes, offering potential for tailored risk stratification and targeted research.

Digital Object Identifier (DOI)